Followers | 35 |
Posts | 6308 |
Boards Moderated | 0 |
Alias Born | 02/09/2015 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 26, 2015 10:26:09 PM
OK recall the curve posted by ?sclimmuno- it showed what you would expect- big pharma pays more for drugs as they are farther along in trials.(duh) If CTIX has enough money for phase 3 why not hold out for more money from a big company? When they are further down the road, and not n the near future? Better for shareholders, ultimately , if they do.
More applications for Brilacidin- I do not have the ability to search prev posts- not a paying ihub customer. Has much been written about non cellulitis applications of the drug?
If not, I can try to add more- and I will gladly defer to any infectious disease docs who follow this board- are there any, by the way?
Any pt with pneumonia admitted to any US hospital who comes from a nursing center or rehab center must be covered for Gm positives, esp MRSA. ALWAYS two drugs, never one drug. Almost automatically this is Vancomycin(plus another antibiotic to cover gm - etc) Here is another potential big market for Brilacidin- so much simpler, as has been detailed, vs Vanco
Yes I am considering buying in a bit, but with 3 daughters in college(and another to come) little to invest. I am sure you know how it goes. Still shareless.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM